0000880771-17-000106.txt : 20170614 0000880771-17-000106.hdr.sgml : 20170614 20170614164818 ACCESSION NUMBER: 0000880771-17-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170612 FILED AS OF DATE: 20170614 DATE AS OF CHANGE: 20170614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhao Hong CENTRAL INDEX KEY: 0001576318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 17911615 MAIL ADDRESS: STREET 1: 30F SHANGHAI TIMES SQUARE, NO. 93 STREET 2: HUAI HAI ROAD CITY: SHANGHAI STATE: F4 ZIP: 200021 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2017-06-12 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001576318 Zhao Hong 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 0 1 0 0 CEO, China Operations Common Stock 2017-06-12 4 M 0 12500 0 A 12500 D Common Stock 2017-06-12 4 M 0 25000 0 A 37500 D Common Stock 2017-06-12 4 M 0 3000 0 A 40500 D Common Stock 2017-06-12 4 S 0 3000 10.75 D 37500 D Common Stock 2017-06-12 4 S 0 12500 10.75 D 25000 D Common Stock 2017-06-12 4 S 0 25000 10.75 D 0 D Restricted Stock Unit 2017-06-12 4 M 0 12500 0 D Common Stock 12500 185000 D Restricted Stock Unit 2017-06-12 4 M 0 25000 0 D Common Stock 25000 160000 D Restricted Stock Unit 2017-06-12 4 M 0 3000 0 D Common Stock 3000 157000 D Granted under the Issuer's 2005 Equity Incentive Plan. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Provided Reporting Person remains employed by the Issuer, 25% of the restricted stock units will vest on each August 9, 2014, August 9, 2015, August 9, 2016, and August 9, 2017, unless the trading window is closed for the Reporting Person on such date, in which case the vesting date will be deferred until the next date that the trading window is open. Provided Reporting Person remains employed by the Issuer, 33.33% of the restricted stock units vested on January 4, 2016, 33.33% will vest on January 3,2017, and 33.34% will vest on January 2, 2017, unless the trading window is closed for the Reporting Person on such date, in which case the vesting date will be deferred until the next date that the trading window is open. Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment. /s/ Wilson W. Cheung, Attorney-in-Fact For: Hong Zhao 2017-06-14